The global acid sphingomyelinase deficiency (ASMD) market consists of drugs that are used for the treatment of ASMD. ASMD is a rare genetic disorder caused due to the deficiency of the enzyme acid sphingomyelinase, which breaks down sphingomyelin. People with ASMD may experience liver disease, lung disease, and other symptoms. The current treatment options for ASMD include enzyme repl... https://www.zupyak.com/p/4476764/t/the-acid-sphingomyelinase-deficiency-asmd-market-is-poised-for-significant-growth-due-to-increasing-research-and-development-activities